AbbVie results beat expectations despite low-cost competition to blockbuster Humira
October 27, 2023 at 07:42 AM EDT
Drugmaker raises its full-year earnings outlook, boosts 2024 dividend 4.7%
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
